Conclusions
There are similarities and differences between Europe and America in the
approach to the diagnosis of BLs hypersensitivity in children. The
diagnosis of BLs hypersensitivity in children is still an important and
hot topic, and continues to be a challenge. It is necessary to educate
the public and health workers about the differences in adverse reactions
to drugs and real drug hypersensitivity reactions ”drug allergies”.
Thus, it could reduce overdiagnosis and promote appropriate procedures,
that will prevent the overlabeling of drug allergy. There is a need to
make a recommendation in pediatric guidelines, but for this, it is
required further studies to validate this.